A Study Observing US Patients With HAE Type I or II Who Take Icatibant to Treat HAE Attacks

NCT07009262 · clinicaltrials.gov ↗

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema

Interventions

OTHER: Inapplicable

Sponsor

KalVista Pharmaceuticals, Ltd.

Collaborators

[object Object]